In a rat model of dimethylhydrazyne-induced colorectal cancer, oral administration of GMP increased the expression of p16 and mucin2 (MUC2), proteins associated with cancer protection, while it attenuated the number of aberrant crypt foci, a cancer establishment indicator [58]. This evidence concerns the gene MUC2 and cancer.